Note that enhanced levels of ATG7, for instance, have been reported in diverse cancer types and were shown to promote cancer survival and resistance to chemotherapy, whereas a downregulation could counteract cancer development, progression and resistance [53,54]. The gene discussed is ATG7; the disease is cancer.